IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
+10.72%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$205M
AUM Growth
+$205M
(-14%)
Cap. Flow
-$60M
Cap. Flow
% of AUM
-29.28%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
12
New
–
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
Venus Concept
VERO
|
$5.8M |
| 2 |
HIND
Vyome Holdings, Inc. Common Stock
HIND
|
$2.97M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$1.3M |
Top Sells
| 1 |
Glaukos
GKOS
|
$65.8M |
| 2 |
IVTY
Invuity, Inc
IVTY
|
$4.21M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $78.9M | 38.51% |
2,021,738
| – | – |
|
2
Neuronetics
STIM
$220M
| $33M | 16.14% |
1,030,689
| – | – |
|
3
MacroGenics
MGNX
$112M
| $23M | 11.25% |
1,074,316
| – | – |
|
|
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $19.2M | 9.37% |
1,599,592
| – | – |
|
|
5
Venus Concept
VERO
$4.11M
| $15.5M | 7.58% |
5,355,786
+2,000,000
| +60% | +$5.8M |
|
|
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $10.6M | 5.19% |
1,455,904
| – | – |
|
|
HIND
7
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $9.59M | 4.68% |
3,552,239
+1,098,901
| +45% | +$2.97M |
|
|
8
KalVista Pharmaceuticals
KALV
$678M
| $8.6M | 4.2% |
388,766
+58,824
| +18% | +$1.3M |
|
9
Cidara Therapeutics
CDTX
$1.66B
| $5.97M | 2.92% |
1,356,813
| – | – |
|
|
10
Glaukos
GKOS
$5.5B
| $218K | 0.11% |
3,362
-1,015,000
| -100% | -$65.8M |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $109K | 0.05% |
8,293
| – | – |
|
|
IVTY
12
DELISTED
Invuity, Inc
IVTY
| – | – |
-1,080,272
| Closed | -$4.21M |
|